Risk of adverse outcome of COVID-19 among patients in secure psychiatric services: observational cohort study
Natasa Basrak,
Naoise Mulcrone,
Sue Sharifuddin,
Zeshan Ghumman,
Nirvana Bechan,
Enas Mohamed,
Michael Murray,
Hariharan Rajendran,
Sean Gunnigle,
Mark Nolan,
Tim Quane,
Masashi Terao,
Tracey Hoare,
Kevin Kirrane,
Harry G. Kennedy,
Mary Davoren
Affiliations
Natasa Basrak
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Naoise Mulcrone
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Sue Sharifuddin
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Zeshan Ghumman
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Nirvana Bechan
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Enas Mohamed
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Michael Murray
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Hariharan Rajendran
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Sean Gunnigle
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Mark Nolan
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland; and DUNDRUM Centre for Forensic Excellence, Trinity College Dublin, Ireland
Tim Quane
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Masashi Terao
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Tracey Hoare
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Kevin Kirrane
National Forensic Mental Health Service, Central Mental Hospital, Dublin, Ireland
Background Secure forensic mental health services treat patients with high rates of treatment-resistant psychoses. High rates of obesity and medical comorbidities are common. Population-based studies have identified high-risk groups in the event of SARS-CoV-2 infection, including those with problems such as obesity, lung disease and immune-compromising conditions. Structured assessment tools exist to ascertain the risk of adverse outcome in the event of SARS-CoV-2 infection. Aims To assess risk of adverse outcome in the event of SARS-CoV-2 infection in a complete population of forensic psychiatry patients using structured assessment tools. Method All patients of a national forensic mental health service (n = 141) were rated for risk of adverse outcome in the event of SARS-CoV-2 infection, using two structured tools, the COVID-Age tool and the COVID-Risk tool. Results We found high rates of relevant physical comorbidities. Mean chronological age was 45.5 years (s.d. = 11.4, median 44.1), mean score on the COVID-Age tool was 59.1 years (s.d. = 19.4, median 58.0), mean difference was 13.6 years (s.d. = 15.6), paired t = 10.9, d.f. = 140, P < 0.001. Three patients (2.1%) were chronologically over 70 years of age, compared with 43 (30.5%) with a COVID-Age over 70 (χ2 = 6.99, d.f. = 1, P = 0.008, Fisher's exact test P = 0.027). Conclusions Patients in secure forensic psychiatric services represent a high-risk group for adverse outcomes in the event of SARS-COV-2 infection. Population-based guidance on self-isolation and other precautions based on chronological age may not be sufficient. There is an urgent need for better physical health research and treatment in this group.